Magic mushrooms tested as potential aid for opioid addiction

NCT ID NCT04161066

Summary

This early-stage study is testing whether psilocybin, the active compound in 'magic mushrooms,' is safe for people with opioid addiction who are taking buprenorphine medication. Researchers will give 10 participants two doses of psilocybin while they continue their regular addiction medication. The main goal is to check for any safety issues when these two substances are combined, while also looking at whether psilocybin might help reduce cravings or improve quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Wisconsin

    RECRUITING

    Madison, Wisconsin, 53705, United States

    Contact

Conditions

Explore the condition pages connected to this study.